Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/20308427

J. Cell Biol. 2010 Mar 22 188 6 851-62

Download in:

View as

General Info

PMID
20308427